Imetelstat in Combination With Paclitaxel (With or Without Bevacizumab) in Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bevacizumab
Related studies linked through entity extraction aliases.
Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)
- Status
- WITHDRAWN
- Phase
- PHASE2
Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.
- Status
- COMPLETED
- Phase
- PHASE3
Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy Surgery
- Status
- WITHDRAWN
- Phase
- PHASE4
Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
- Status
- COMPLETED
- Phase
- PHASE1
Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
- Status
- UNKNOWN
- Phase
- PHASE2
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab
- Status
- COMPLETED
- Phase
- PHASE1